​

Funding Round

Series B - Science 37

Series B - Science 37

Investment Firm

Overview

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

Announced Date

Oct 18, 2016

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Redmile Group

Redmile Group

Redmile Group is a early_stage_venture and late_stage_venture and post_ipo and private_equity firm.

Participant Investors

5

Investor Name
Participant InvestordRx Capital
Participant InvestorRedmile Group
Participant InvestorSanofi Ventures
Participant InvestorArthur Iinuma
Participant InvestorLux Capital

Round Details and Background

Science 37 raised $31000000 on 2016-10-18 in Series B

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 07, 2021
Post-IPO Equity - Science 37
14-200.0M
Apr 25, 2017
Series C - Science 37
7-35.0M
Oct 18, 2016
Series B - Science 37
5-31.0M
Oct 20, 2015
Series A - Science 37
3-6.5M

Recent Activity

There is no recent news or activity for this profile.